Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer
Di Leo, Angelo, Jerusalem, Guy, Petruzelka, Lubos, Torres, Roberto, Bondarenko, Igor N, Khasanov, Rustem, Verhoeven, Didier, Pedrini, José L, Smirnova, Iya, Lichinitser, Mikhail R, Pendergrass, Kelly, Garnett, Sally, Lindemann, Justin P O, Sapunar, Francisco, Martin, Miguel
Published in Journal of clinical oncology (20.10.2010)
Published in Journal of clinical oncology (20.10.2010)
Get full text
Journal Article
Web Resource
Frequency of hemochromatosis gene ( HFE) mutations in Russian healthy women and patients with estrogen-dependent cancers
Kondrashova, Tatiana V., Neriishi, Kazuo, Ban, Sadayuki, Ivanova, Tatiana I., Krikunova, Lyudmila I., Shentereva, Nataliya I., Smirnova, Iya A., Zharikova, Irina A., Konova, Marina V., Taira, Senjun, Tsyb, Anatoly F.
Published in Biochimica et biophysica acta (2006)
Published in Biochimica et biophysica acta (2006)
Get full text
Journal Article
Final overall survival: fulvestrant 500 mg vs 250 mg in the randomized CONFIRM trial
Di Leo, Angelo, Jerusalem, Guy, Petruzelka, Lubos, Torres, Roberto, Bondarenko, Igor N, Khasanov, Rustem, Verhoeven, Didier, Pedrini, José L, Smirnova, Iya, Lichinitser, Mikhail R, Pendergrass, Kelly, Malorni, Luca, Garnett, Sally, Rukazenkov, Yuri, Martin, Miguel
Published in JNCI : Journal of the National Cancer Institute (01.01.2014)
Published in JNCI : Journal of the National Cancer Institute (01.01.2014)
Get full text
Journal Article
Web Resource
A randomized, double-blind phase II trial of exemestane plus MM-121 (a monoclonal antibody targeting ErbB3) or placebo in postmenopausal women with locally advanced or metastatic ER+/PR+, HER2-negative breast cancer
Higgins, Michaela Jane, Doyle, Catherine, Paepke, Stefan, Azaro, Analia, Martin, Miguel, Semiglazov, Vladimir, Smirnova, Iya, Krasnozhon, Dmitriy, Manikhas, Alexey, Harb, Wael A., Panasci, Lawrence C., Pearlberg, Joseph, MacBeath, Gavin, Nering, Rachel, Goss, Paul E., Miller, Kathy
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Final Overall Survival: Fulvestrant 500mg vs 250mg in the Randomized CONFIRM Trial
Di Leo, Angelo, Jerusalem, Guy, Petruzelka, Lubos, Torres, Roberto, Bondarenko, Igor N, Khasanov, Rustem, Verhoeven, Didier, Pedrini, José L, Smirnova, Iya, Lichinitser, Mikhail R, Pendergrass, Kelly, Malorni, Luca, Garnett, Sally, Rukazenkov, Yuri, Martin, Miguel
Published in JNCI : Journal of the National Cancer Institute (01.01.2014)
Get full text
Published in JNCI : Journal of the National Cancer Institute (01.01.2014)
Journal Article
Final Overall Survival: Fulvestrant 500mg vs 250mg in the Randomized CONFIRM Trial
Leo, Angelo Di, Jerusalem, Guy, Petruzelka, Lubos, Torres, Roberto, Bondarenko, Igor N., Khasanov, Rustem, Verhoeven, Didier, Pedrini, José L., Smirnova, Iya, Lichinitser, Mikhail R., Pendergrass, Kelly, Malorni, Luca, Garnett, Sally, Rukazenkov, Yuri, Martin, Miguel
Published in JNCI : Journal of the National Cancer Institute (07.12.2013)
Published in JNCI : Journal of the National Cancer Institute (07.12.2013)
Get full text
Journal Article
Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM Trial
DI LEO, Angelo, JERUSALEM, Guy, PENDERGRASS, Kelly, MALORNI, Luca, GARNETT, Sally, RUKAZENKOV, Yuri, MARTIN, Miguel, PETRUZELKA, Lubos, TORRES, Roberto, BONDARENKO, Igor N, KHASANOV, Rustem, VERHOEVEN, Didier, PEDRINI, José L, SMIRNOVA, Iya, LICHINITSER, Mikhail R
Published in JNCI : Journal of the National Cancer Institute (2014)
Get full text
Published in JNCI : Journal of the National Cancer Institute (2014)
Journal Article
Application of new methodology to allow comparison of duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial
Garnett, Sally, Martin, Miguel, Jerusalem, Guy, Petruzelka, Lubos, Torres, Roberto, Bondarenko, Igor N, Khasanov, Rustem, Verhoeven, Didier, Pedrini, José L, Smirnova, Iya, Lichinitser, Mikhail R, Pendergrass, Kelly, Lindemann, Justin P.O, Di Leo, Angelo
Published in Breast (Edinburgh) (01.10.2011)
Published in Breast (Edinburgh) (01.10.2011)
Get full text
Journal Article
Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor-Positive Advanced Breast Cancer
DI LEO, Angelo, JERUSALEM, Guy, PENDERGRASS, Kelly, GARNETT, Sally, LINDEMANN, Justin P. O, SAPUNAR, Francisco, MARTIN, Miguel, PETRUZELKA, Lubos, TORRES, Roberto, BONDARENKO, Igor N, KHASANOV, Rustem, VERHOEVEN, Didier, PEDRINI, José L, SMIRNOVA, Iya, LICHINITSER, Mikhail R
Published in Journal of clinical oncology (2010)
Get full text
Published in Journal of clinical oncology (2010)
Journal Article